Back to overview

Iron and Zinc in ADHD

When nutrient deficiency affects ADHD symptoms

Something Worth Checking



Most conversations about ADHD and nutrition revolve around sugar, additives, omega-3. All relevant.

But two micronutrients are surprisingly often overlooked: iron and zinc. Both are directly involved in dopamine synthesis. Both show clear relationships with ADHD severity in studies.

And both can be measured.

Iron and the Dopamine System



Iron is a cofactor of tyrosine hydroxylase – the enzyme that converts tyrosine into L-DOPA, the immediate precursor to dopamine. Without enough iron, this step runs inefficiently.

Konofal et al. (2004) studied iron levels in children with ADHD and compared them to a control group. Result: 84 percent of children with ADHD had ferritin levels below 30 µg/l – the proportion in the control group was 18 percent. That's a substantial difference.

Konofal et al. (2008) followed with a randomized controlled trial: iron supplementation in children with ADHD and low ferritin measurably improved ADHD symptoms after 12 weeks. Not as strongly as medication – but significantly.

Ferritin is the more important value than serum iron. Low ferritin means empty iron stores, even when serum iron levels still appear normal.

Zinc and the Dopamine-Serotonin Balance



Zinc plays several roles in the brain: it regulates dopamine receptor function, influences melatonin synthesis, and has an inhibitory effect on the dopamine transporter – the mechanism that recaptures dopamine from the synaptic cleft.

Arnold et al. (2005) analyzed zinc levels in children with ADHD in a study from Iran, where zinc deficiency is more common. Children with low zinc levels showed more severe ADHD symptoms. Zinc supplementation showed modest but measurable improvements.

Another finding: zinc deficiency appears to modulate the effectiveness of amphetamines. Children with higher zinc levels responded to lower stimulant doses.

What This Means in Daily Life



Important: iron and zinc supplementation only helps when there's actually a deficiency. Uncontrolled self-supplementation with iron can be dangerous. High-dose zinc inhibits copper absorption.

That means: measure before you supplement.

What you can get tested:
- Ferritin (iron stores) – the more relevant value
- Serum zinc or urinary zinc
- Optional addition: copper (since zinc supplementation affects copper levels)

This is a standard or extended blood panel at your doctor's office. Not a big deal.

Diet as a Foundation



Regardless of test results: foods rich in iron and zinc are nutritionally sensible in general.

Iron-rich foods:
- Red meat (especially well-absorbed heme iron)
- Legumes (lentils, chickpeas)
- Spinach, kale (vitamin C alongside improves absorption)
- Pumpkin seeds, sesame

Zinc-rich foods:
- Oysters (very high content)
- Red meat
- Pumpkin seeds, hemp seeds
- Whole grains, legumes

What the German S3 Guideline Recommends



The German S3 guideline on ADHD mentions nutrient deficiencies as potentially relevant factors. Explicitly recommended: especially in children with unclear symptom severity or poor response to standard therapy, micronutrient testing should be considered.

That's not a niche recommendation – it's medical consensus.

If you have ADHD and your levels have never been measured: that's a question worth asking at your next doctor's appointment.

---

Disclaimer: This article is for educational purposes and does not replace medical or nutritional advice. Supplementation should only be done after medical consultation.

Sources



- Konofal, E., et al. (2004). Iron deficiency in children with attention-deficit/hyperactivity disorder. *Archives of Pediatrics & Adolescent Medicine*, 158(12), 1113–1115. [PubMed](https://pubmed.ncbi.nlm.nih.gov/15583094/)
- Konofal, E., et al. (2008). Effects of iron supplementation on attention deficit hyperactivity disorder in children. *Pediatric Neurology*, 38(1), 20–26. [PubMed](https://pubmed.ncbi.nlm.nih.gov/18054688/)
- Arnold, L.E., et al. (2005). Zinc for attention-deficit/hyperactivity disorder. *Journal of Child and Adolescent Psychopharmacology*, 15(4), 628–636. [PubMed](https://pubmed.ncbi.nlm.nih.gov/16190793/)